Stock Movers: EA LBO, Weed Stocks Surge on Trump Comments, Genmab Acquires Merus

Electronic Arts (EA) Leveraged Buyout

• 🚀 Electronic Arts (EA) shares surged up to 5% on news of an agreement to be sold to a group of private investors.
• 💰 The deal values EA at approximately $55 billion, marking the largest leveraged buyout on record.
• 🤝 The investor group includes Silver Lake Management, Saudi Arabia's Public Investment Fund, and Jared Kushner's Affinity Partners.
• 💸 They will pay $210 per share in cash, a 25% premium to its trading price before the talks leaked.
• 🏦 JP Morgan Chase is providing $20 billion in debt financing for the transaction.
• 📉 The buyout comes as the video game industry, which soared during the pandemic, has been slowing down, leading to layoffs and consolidation.
• 🎯 Going private will allow EA to avoid quarterly earnings pressures and focus on upcoming releases like Battlefield 6.

Weed Stocks Surge on Trump's CBD Comments

• 📈 Tilray Brands (TLRY) saw its shares rise by 16% following comments from President Donald Trump.
• 🗣️ Trump posted a video praising the medical benefits of hemp-derived CBD for seniors and suggested covering it under Medicare.
• 💰 He also highlighted the potential economic benefits of medical marijuana legalization, estimating cost savings of $64 billion annually if cannabis is integrated into healthcare.
• 🌿 This news has also sparked interest in other weed stocks like Cronos and Canopy Growth.

Occidental Petroleum Divestment

• 📊 Occidental Petroleum (OXY) shares gained about 1.5% on a Financial Times report.
• 💰 The company is reportedly in talks to sell its OxyChem unit for at least $10 billion.
• 🏭 This potential sale could create one of the world's largest standalone petrochemical companies.
• 📉 Occidental Petroleum has been divesting assets to reduce debt, a strategy supported by Warren Buffett.

Genmab Acquires Merus

• ✨ Danish biotechnology company Genmab has agreed to acquire Dutch drugmaker Merus.
• 💰 The all-cash transaction has an approximate value of $8 billion.
• 🔬 Merus is developing a cancer treatment, particularly for head and neck cancers.
• 📈 Merus shares surged as much as 37% on the acquisition news.